Target intelligence / Profile preview

Non-specific biological surfaces

Molecular classification
Other
01

Overview

Non-specific biological surfaces refers to the broad category of biological interfaces—such as cell membranes, mucosal layers, or the gastrointestinal lining—that interact with therapeutic agents through non-selective physical or chemical forces rather than specific molecular recognition (Bylund & Toews, 1993). Unlike traditional drug targets like receptors or enzymes, these surfaces do not possess specific binding pockets; instead, they facilitate interactions such as adsorption, lubrication, or the modification of surface tension (Zellner et al., 2019). Common examples of agents acting on these surfaces include activated charcoal, which adsorbs toxins to prevent their systemic absorption, and surfactants like simethicone that alter gas bubble dynamics to relieve flatulence (PubChem CID 6433516). Lubricants such as mineral oil or glycerin also act on these surfaces by providing a physical coating that facilitates movement or prevents desiccation (Mayo Clinic, 2023). Because these interactions lack molecular specificity, they are often characterized by high-capacity binding and can lead to non-selective interference with the pharmacokinetics of other drugs (Goodman & Gilman, 2018). This classification is typically utilized for agents whose therapeutic utility is derived from their bulk physical properties rather than targeted molecular signaling pathways. Consequently, these targets are often considered non-pharmacological in the traditional sense, as they do not involve specific ligand-protein interactions.

Other names
Non-specific binding sitesBiological interfacesNon-specific surfaces
02

Mechanism of action

Physical adsorption of molecules, reduction of interfacial surface tension, and mechanical lubrication of mucosal surfaces.

03

Biological functions

Physical barrier maintenanceSurface tension regulationAdsorption of exogenous substances
04

Disease associations

PoisoningFlatulenceConstipationDry eye syndrome
05

Safety considerations

Reduced bioavailability of co-administered drugsPotential for lipid-soluble vitamin deficiencyGastrointestinal transit alterations
06

Interacting drugs

Activated charcoal

5 more in the full profile.

Beyond the preview

Go deeper on Non-specific biological surfaces.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Non-specific biological surfaces.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call